首页> 外文期刊>Clinical nuclear medicine >F-18-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma
【24h】

F-18-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma

机译:F-18-FDG PET / CT转移性甲状旁腺癌的骨代谢活性

获取原文
获取原文并翻译 | 示例
           

摘要

Parathyroid cancer is an uncommon type of malignancy, which is frequently associated with poor prognosis. Clinical manifestations are caused by elevated serum calcium and parathyroid hormone (PTH). Diagnostic imaging studies as neck ultrasonography, technetium Tc Tc-99m-sestamibi whole body scintigraphy, CT, and MR are already established tools for this malignancy. Nevertheless, the role of F-18-FDG PET/CT remains unknown in this scenario, with few published studies in literature. Hence, in this article, we aimed to report an illustrative case of increased skeletal FDG uptake associated with high calcium and PTH levels.
机译:甲状旁腺癌是一种罕见的恶性肿瘤,通常与不良预后有关。临床表现是由血清钙和甲状旁腺激素(PTH)升高引起的。诊断成像研究如颈部超声检查,tech Tc Tc-99m-司他他比全身闪烁显像,CT和MR已经成为解决这种恶性肿瘤的工具。然而,在这种情况下F-18-FDG PET / CT的作用仍然未知,文献中很少有已发表的研究。因此,在本文中,我们旨在报告与高钙和PTH水平相关的骨骼FDG摄取增加的示例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号